Fennec Pharmaceuticals (FENC) EBT Margin: 2011-2025
Historic EBT Margin for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to -5.00%.
- Fennec Pharmaceuticals' EBT Margin rose 7689.00% to -5.00% in Q3 2025 from the same period last year, while for Sep 2025 it was -16.61%, marking a year-over-year decrease of 1471.00%. This contributed to the annual value of -0.15% for FY2024, which is 7535.00% up from last year.
- Latest data reveals that Fennec Pharmaceuticals reported EBT Margin of -5.00% as of Q3 2025, which was up 84.71% from -32.69% recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' EBT Margin registered a high of 122,775.00% during Q1 2021, and its lowest value of -355.34% during Q1 2023.
- Moreover, its 3-year median value for EBT Margin was -27.18% (2023), whereas its average is -68.00%.
- As far as peak fluctuations go, Fennec Pharmaceuticals' EBT Margin crashed by 11,657,672bps in 2022, and later surged by 40,619bps in 2024.
- Over the past 5 years, Fennec Pharmaceuticals' EBT Margin (Quarterly) stood at 7,663.64% in 2021, then slumped by 94,599bps to 1,130.53% in 2022, then crashed by 115,742bps to -26.89% in 2023, then soared by 795bps to -18.94% in 2024, then surged by 7,689bps to -5.00% in 2025.
- Its EBT Margin stands at -5.00% for Q3 2025, versus -32.69% for Q2 2025 and -13.30% for Q1 2025.